NRCME DOT Examiner Test Practice Questions with Revised Answers
7 views 0 purchase
Course
NRCME
Institution
NRCME
NRCME DOT Examiner Test Practice Questions with Revised Answers
Which of the following is not true in regards to antidepressant therapy?
A. Second generation antidepressants, including fluoxetine and venlafaxine, have fewer side effects than first generation antidepressants and are generally sa...
NRCME DOT Examiner Test Practice
Questions with Revised Answers
Which of the following is not true in regards to antidepressant therapy?
A. Second generation antidepressants, including fluoxetine and venlafaxine, have fewer
side effects than first generation antidepressants and are generally safe
B. Guidelines recommend a case-by-case assessment of drivers treated with
antidepressant medication
C. First generation antidepressants, which include tricyclics such as amitriptyline and
imipramine, have consistently been shown to interfere with safe driving
D. With long-term use of antidepressants, most drivers never develop a tolerance to the
sedative effects - Answer-D. With long-term use of antidepressants, most drivers never
develop a tolerance to the sedative effects
Guidelines recommend a case-by-case assessment of drivers treated with
antidepressant medication. With long-term use of antidepressants, most drivers tend to
develop a tolerance to the sedative effects. First generation antidepressants, which
include tricyclics such as amitriptyline and imipramine, have consistently been shown to
interfere with safe driving. Lastly, second generation antidepressants, including
fluoxetine and venlafaxine, have fewer side effects and are generally safe.
When deciding if a commercial driver should be medically certified, what is the
fundamental question a medical examiner should examine in regards to cardiovascular
health?
A. What is the likelihood that he or she will contract a cardiovascular disease?
B. Does his or her family have a history of cardiovascular disease?
C. Has the driver ever had a cardiovascular disease?
D. Does the driver have a cardiovascular disease that increases the risk of sudden
death or incapacitation? - Answer-D. Does the driver have a cardiovascular disease that
increases the risk of sudden death or incapacitation?
When looking at the cardiovascular health of a driver, the fundamental question is
whether the driver has a cardiovascular disease that increases the risk of sudden death
or incapacitation, creating a danger to the safety and health of the driver, as well as the
public sharing the road. While history and family history of such diseases are important,
they are not the fundamental questions necessary about which to ask.
An implantable cardioverter-defibrillator is:
, A. A type of arrhythmia categorized as ventricular fibrillation and ventricular tachycardia
and is responsible for the majority of instances of cardiac sudden death
B. A type of arrhythmia that is usually not considered a risk for sudden death
C. An implantable device designed to treat bradycardia
D. An electronic device that treats cardiac arrest, ventricular fibrillation, and ventricular
tachycardia through the delivery of rapid pacing stimuli or shock therapy - Answer-D. An
electronic device that treats cardiac arrest, ventricular fibrillation, and ventricular
tachycardia through the delivery of rapid pacing stimuli or shock therapy
An implantable cardioverter-defibrillator is An electronic device that treats cardiac arrest,
ventricular fibrillation, and ventricular tachycardia through the delivery of rapid pacing
stimuli or shock therapy. A pacemaker is an implantable device designed to treat
bradycardia. Also, supraventricular tachycardia is a type of arrhythmia that is usually not
considered a risk for sudden death. Lastly, ventricular arrhythmia is a type of arrhythmia
categorized as ventricular fibrillation and ventricular tachycardia and is responsible for
the majority of instances of cardiac sudden death.
Which of the following is not true about the risk from headaches?
A. Headache and chronic "nagging" pain may be present to such a degree that
certification for driving is inadvisable
B. Most headaches, vertigo, and dizziness are consequential, causing a danger for
drivers that experience such conditions
C. Disorders with incapacitating symptoms, even if periodic or in the early stages of
disease, warrant the decision to not certify the driver
D. Medication used to treat headaches may further interfere with safe driving - Answer-
B. Most headaches, vertigo, and dizziness are consequential, causing a danger for
drivers that experience such conditions
The symptoms of headaches, vertigo, and dizziness are typically inconsequential, but
they still constitute a problem for a driver. Headache and chronic "nagging" pain may be
present to such a degree that certification for driving is inadvisable. Also, medication
used to treat headaches may further interfere with safe driving. Lastly, disorders with
incapacitating symptoms, even if periodic or in the early stages of disease, warrant the
decision to not certify the driver.
Which of the following is true in regards to an implantable cardioverter-defibrillator?
A. Combination ICD/pacemaker devices are also effective in preventing incapacitation
cardiac and arrhythmia events
B. Management of the underlying disease is effective enough for the driver to meet
cardiovascular qualification requirements
C. ICDs treat and prevent arrhythmias
D. Drivers are at a risk for syncope - Answer-D. Drivers are at a risk for syncope
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller Scholarsstudyguide. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $11.49. You're not tied to anything after your purchase.
